Showing results (11-20 of 135) with videos related to
Sort By:
Pageof 14
Health Affairs (Project Hope)|September 10, 2014
The hidden cost of low prices: limited access to new drugs in IndiaErnst R Berndt, Iain M CockburnJournal of Managed Care & Specialty Pharmacy|April 26, 2022
Ensuring a high-quality and resilient supply chain of essential medications means paying moreT Joseph Mattingly, Rena M ContiF1000Research|November 18, 2020
Public research funding and pharmaceutical prices: do Americans pay twice for drugs?Rena M Conti, Frank S DavidHealth Affairs (Project Hope)|October 8, 2014
The 340B drug discount program: hospitals generate profits by expanding to reach more affluent communitiesRena M Conti, Peter B BachHealth Affairs (Project Hope)|October 5, 2020
Trends In Orphan Drug Spending And Out-Of-Pocket Spending Among US Children, 2013-18Kao-Ping Chua, Rena M ContiAmerican Journal of Preventive Medicine|February 22, 2021
Out-of-Pocket Spending for Influenza Hospitalizations in Medicare AdvantageKao-Ping Chua, Rena M ContiJournal of Health Politics, Policy and Law|December 24, 2016
Policy Diffusion across Disparate Disciplines: Private- and Public-Sector Dynamics Affecting State-Level Adoption of the ACARena M Conti, David K JonesJournal of Health Politics, Policy and Law|July 22, 2022
International Reference Pricing in the Context of US Drug PolicyRichard Frank, Rena M Conti, Jonathan GruberScience Translational Medicine|December 4, 2024
Predicting the next round of drugs for Medicare price negotiationMatthew Vogel, Adam Tellier, Rena M ContiThe Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|July 28, 2022
Opportunities and Challenges of Generic Pre-Exposure Prophylaxis Drugs for HIVJeromie Ballreich, Timothy Levengood, Rena M ContiPageof 14